Effect of Methamphetamine Addiction on Brain Chemistry Through the Adoption of Fractalkine as an Indicator

Authors

  • Mushtaq T. Abood1 , Lamia A. Almashhedy1

Keywords:

CX3CL1. Fractalkine .CX3CR1. Chemokines. Methamphetamine. blood–brain barrier (BBB).

Abstract

Methamphetamine (METH), a highly addictive drug and a strong stimulant of the central nervous system.

METH abuse is increasing, especially among young people and adolescents, and therefore we wanted in this

research to shed light on some of the problems resulting from meth use, especially its effect on the central

nervous system, the blood-brain barrier, and Fractalkine (CX3CL1).

CX3CL1 is the only member of the CX3C subcategory of chemokines, which have a major role in the

central nervous system by regulating interactions between neurons, glial cells, and immune cells. It is also

considered heavily involved in traumatic brain injury (TBI) and spinal cord injury (SCI).

The study was conducted on eighty people divided into three groups, thirty non addicted men as a control

group(G1), taking into account and excluding, cigarette smoking, age, social and cultural conditions, and

chronic diseases, also thirty people addicted to methamphetamine(G2), and twenty people addicted to

methamphetamine and other narcotic substances (mix)(G3), whose ages ranged between (15-45) years and

the period of methamphetamine abuse ranged between (1-7) years.

The results of study showed that CX3CL1 values were higher among addicted persons compared to non

addicts (G1), this difference in values shows us the effect of meth on the total values of CX3CL1.

Author Biography

Mushtaq T. Abood1 , Lamia A. Almashhedy1

1 Msc. Student/ Ministry of interior/Federal security agency/ Border Guard Force Command, Baghdad, Iraq

Published

2020-07-30

How to Cite

Mushtaq T. Abood1 , Lamia A. Almashhedy1. (2020). Effect of Methamphetamine Addiction on Brain Chemistry Through the Adoption of Fractalkine as an Indicator. Indian Journal of Forensic Medicine & Toxicology, 14(3), 2343-2350. Retrieved from http://medicopublication.com/index.php/ijfmt/article/view/10785